Ustekinumab vs Infliximab in CD
Ritlecitinib and Brepocitinib in UC
Infliximab or azathioprine withdrawal in CD
Diverting ileostomy closure after pouch construction
Tofacitinib in acute severe ulcerative colitis
Phase 2 trial, guselkumab in Crohn’s disease efficacy and safety at week 48
Allopurinol-thiopurine versus standard thiopurine in patients with IBD
LAG-3 depleting antibody GSK2831781 in UC
Upadacitinib in Crohn’s disease induction and maintenance
Adalimumab increased interval in CD